Loading
NYSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$9.32
+$0.065 · +0.70%
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Previous close
$9.32
+$0.065 · +0.70%
Regular session · ET · Market data may be delayed.
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Day range
Current $9.32
52-week range
Current $9.32
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
88
Deep Value
Sentiment
52
Mixed
Risk
22
Moderate Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Day range
Current $9.32
52-week range
Current $9.32
Third-party consensus; not a GoAI recommendation.
Average target
$10.20
9.44% upsideFunds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR Portfolio Developed World ex-US ETFSPDW50.71M0.13%40.46B USD0.03%$49.98+0.64%
VanEck Pharmaceutical ETFPPH39M3.80%1.04B USD0.36%$110.49+1.20%
Principal Exchange-Traded Funds - Principal International Equity ETFPIEQ32.95M2.49%1.3B USD0.48%$35.59+0.57%
Avantis International Equity ETFAVDE8.54M0.04%19.22B USD0.23%$89.80+0.58%
Portfolio Building Block World Pharma and Biotech Index ETFPBPH5.65M0.55%1.03B USD0.13%$28.3551+1.40%
Scharf Global Opportunity ETFGKAT4.36M2.65%164.63M USD0.59%$44.7957+0.66%
ETF Opportunities Trust - AQE Core ETFAQEC4.25M0.70%604.72M USD0.49%$26.02+0.35%
Franklin ClearBridge Enhanced Income ETFYLDE3.95M2.27%174.79M USD0.48%$55.525+0.31%State Street SPDR Portfolio Developed World ex-US ETFSPDWVanEck Pharmaceutical ETFPPHPrincipal Exchange-Traded Funds - Principal International Equity ETFPIEQAvantis International Equity ETFAVDEPortfolio Building Block World Pharma and Biotech Index ETFPBPHScharf Global Opportunity ETFGKATETF Opportunities Trust - AQE Core ETFAQECFranklin ClearBridge Enhanced Income ETFYLDEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
